ClinicalTrials.Veeva

Menu

Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage

U

Università degli Studi dell'Insubria

Status and phase

Unknown
Phase 4

Conditions

Continuous Positive Airway Pressure Ventilation
Cardiac Remodelling
Sleep Apnea Syndrome
Metabolic Syndrome

Treatments

Behavioral: dietary and life style recommendations
Device: continuous positive airway pressure ventilation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To assess in moderate to severe Obstructive Sleep Apnea the effects of one year therapy with nighttime continuous positive airway pressure ventilation on the prevalence of metabolic syndrome and cardiovascular damage.

Enrollment

100 estimated patients

Sex

All

Ages

25 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • moderate to severe sleep apnea syndrome

Exclusion criteria

  • cardiovascular diseases (coronary artery disease, stroke, peripheral artery disease)
  • thyroid diseases
  • diabetes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

1
Experimental group
Description:
continuous positive airway pressure ventilation + dietary and life style recommendations
Treatment:
Behavioral: dietary and life style recommendations
Device: continuous positive airway pressure ventilation
Behavioral: dietary and life style recommendations
2
Active Comparator group
Description:
dietary and life style recommendations
Treatment:
Behavioral: dietary and life style recommendations
Behavioral: dietary and life style recommendations

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems